$ACTU

$0.36▲ +5.9% YTD

6 SEC 13D/G filings tracked · Last updated Nov 4, 2026

Filing History

ACTU ▲ +5.9% - Actuate Therapeutics, Inc. Common stock

CP $0.36▲ +5.9%Nov 4, 2026 · ThinkSabio Blog

$ACTU - Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in…

News

ACTU ▲ +11.8% - Actuate Therapeutics, Inc. Common stock

CP $0.38▲ +11.8%Nov 2, 2026 · ThinkSabio Blog

$ACTU - Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets…

SEC 13D/G

ACTU - Actuate Therapeutics, Inc. Common stock - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks Simplified

$0.34▼ -94.30%Oct 30, 2026 · ThinkSabio Blog

$ACTU SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACTU Actuate Therapeutics, Inc. Common stock : $0.34 Sector: He…

News

ACTU ▼ -27.5% - Actuate Therapeutics, Inc. Common stock

CP $0.37▲ -27.5%Oct 27, 2026 · ThinkSabio Blog

$ACTU - Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering…

News

ACTU ▼ -8.8% - Actuate Therapeutics, Inc. Common stock

CP $1.25▲ -8.8%Sep 9, 2026 · ThinkSabio Blog

$ACTU - Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference…

News

ACTU ▼ -0.7% - Actuate Therapeutics, Inc. Common stock

CP $1.36▲ -0.7%Sep 9, 2026 · ThinkSabio Blog

$ACTU - Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Dar…